Levels of Serum Cytokines and Acute Phase Proteins in Patients With Essential and Cancer-Related Thrombocytosis
- 1 April 2003
- journal article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 26 (2), 135-140
- https://doi.org/10.1097/00000421-200304000-00007
Abstract
Essential thrombocytosis (ET) is a myeloproliferative disorder resulting in an increased production of abnormal platelets. Reactive thrombocytosis (RT) is occasionally observed in clinical situations including chronic inflammation and malignancy. The aim of the present study was to evaluate the discriminatory efficiency of various laboratory tests in patients with ET and cancer-related RT. Forty-five patients with ET, 52 patients with RT, and 25 age-matched normal individuals comprised the study population. Plasma interleukin-1 alpha (IL-1a), IL-2, IL-6, tumor necrosis factor alpha (TNF-a), platelets, hematocrit, hemoglobin, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), lactate dehydrogenase (LDH) and ferritin were determined. We found increased levels of ferritin, LDH, CRP, ESR, IL-1a, and IL-6 in RT compared with ET (p < 0.01 to p < 0.0005). Hemoglobin, hematocrit, and platelets were significantly lower in RT than in ET (p < 0.0005). Furthermore, ferritin and ESR were negatively correlated with Hct, hemoglobin, and TNF-a, whereas ferritin was positively correlated with ESR, IL-1a, IL-6, and CRP, and IL-1a was positively correlated with IL-6. We consider that the aforementioned parameters should be included in the investigation of unexplained thrombocytosis for the differentiation of essential from cancer related thrombocytosis.Keywords
This publication has 19 references indexed in Scilit:
- Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosisJournal of Laboratory and Clinical Medicine, 1999
- Cytokines and the hepatic acute phase responseThe Journal of Pathology, 1997
- Diagnostic and Differential Criteria of Essential Thrombocythemia and Reactive ThrombocytosisLeukemia & Lymphoma, 1996
- Megakaryocyte-Related Interleukins in Reactive Thrombocytosis versus Autonomous ThrombocythemiaActa Haematologica, 1996
- Effects of lnterleukin-1 and Tumor Necrosis Factor on Megakaryocytopoiesis: Mechanism of Reactive ThrombocytosisActa Haematologica, 1995
- Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosisAmerican Journal Of Medicine, 1994
- Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patientsCancer, 1991
- The Role of Interleukin-1 in HematopoiesisActa Haematologica, 1991
- Interaction of monocytes and T cells in the regulation of normal human megakaryocytopoiesis in vitro: role of IL‐1 and IL‐2British Journal of Haematology, 1990
- Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.Journal of Clinical Pathology, 1986